Nanostructured barrier films formed by hydrogen-bonding processed amylopectin with cellulose fibers to enhance oxygen and water vapor resistance in paper-based packaging. The approach uses thermal activation to create a grafted network that improves barrier performance while maintaining recyclability for sustainable packaging applications.
This solution develops nanostructured barrier films by thermally grafting processed amylopectin onto cellulose fibers through hydrogen bonding. The resulting amylopectin-cellulose network forms barrier layers on or within paper substrates, significantly improving resistance to oxygen and water vapor transmission. This technology addresses a critical need in sustainable packaging by replacing conventional petroleum-based barrier coatings with bio-based, recyclable alternatives. The composites have demonstrated stable performance across multiple recycling cycles, supporting circular economy goals in paper packaging applications.
Material composition:
Performance highlights:
Process advantages:
This technology is at an early-to-mid stage of development. Preliminary validation has been completed, including nitrogen absorption and penetration testing, SEM nanostructure characterization, and water absorption assessments. Future work over approximately one year will focus on optimizing thermal hydrogen bonding parameters, scaling chemical processing for amylopectin resizing, and conducting systematic oxygen and water vapor transmission testing on flexible paper packaging prototypes. Recyclability validation through repeated manufacturing and transmission cycles will confirm commercial readiness for sustainable packaging applications.
The University of Oklahoma is a flagship public research university spanning Norman, Oklahoma City, and Tulsa, combining comprehensive academics with a major health sciences center. Industry collaborates through a research and technology campus in Norman that co‑locates university facilities with federal partners, and through the OU Health Sciences Center, which connects clinicians, core labs, and clinical trials within the OU Health system. Dedicated corporate engagement and contracting teams streamline sponsored research, while a centralized technology commercialization office supports IP, licensing, and startup formation. Research is supported by competitive federal funding from agencies such as NIH, NSF, DOE, and DoD.